In this review, the pathophysiological roles of CX3CR1/fractalkine signalling in microglia and neurons at different stages of Alzheimer’s disease and the possible role of CX3CR1/Tau signalling has been widely discussed. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.